Cellomatics has been awarded a grant from the University of Derby’s Capital Growth Fund Programme to support the purchase of new equipment.
CEO and Founder, Dr Shailendra Singh comments: “This is extremely encouraging news as the grant funding further strengthens our CRO capabilities. Our vision has always been to constantly strive and add value to the drug discovery services offered to our clients. Thanks to this funding support from the University of Derby’s Capital Growth Fund Programme that is helping us achieve these objectives”
This grant has been awarded under the European Commission’s De Minimis Regulation (EU) No 1407/2013. This offer of the grant is supported by the Ministry for Housing, Communities and Local Government (MHCLG) and the European Regional Development Fund (ERDF).
